News Archives - Page 25 of 1183 - BioHealth Innovation

News

September 23, 2024

AstraZeneca’s FluMist approved for self-administration in the US

WILMINGTON, Del., September 20, 2024 – FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST,…

Andy

Love0

EVRSocialMediaImage4forPostsAFTER5.30.24

News

September 23, 2024

USP Seeks Expert Volunteers for the 2025-2030 Cycle

U.S. Pharmacopeia (USP) is currently seeking Expert Volunteers from diverse professional backgrounds to contribute to its vital mission of safeguarding…

Andy

Love0

News

September 20, 2024

MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases

ROCKVILLE, Md. and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading,…

Andy

Love0

News

September 20, 2024

Activation Capital Launches Start-the-Journey: Pre-Accelerator Program

RICHMOND, Va., Sept. 17, 2024 /PRNewswire/ -- Activation Capital proudly announces the launch of Start-the-Journey, a new BioHealth Pre-Accelerator designed to equip early-stage…

Andy

Love0

News

September 20, 2024

ARPA-H Launches Initiative for Emerging Health Innovators

What’s happening? ARPA-H is launching the Emerging Health Innovators (EHI) Initiative to increase access to government research funding for early…

Andy

Love0

News

September 20, 2024

Astellas Announces FDA Listing of DIGITIVA™ for the Management of Heart Failure

TOKYO, September 18, 2024 — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that DIGITIVA™, a…

Andy

Love0

News

September 20, 2024

BHI Partner Children’s National Innovation District: New federally supported hub to advance solutions for pediatric health emergencies

Clinicians caring for children are often left to rely on off-label devices and medications approved for adults, especially during national…

Andy

Love0

News

September 19, 2024

Fierce Biotech: NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines

With COVID-19 still spreading and mpox emerging as a public health emergency of international concern, the National Institutes of Health…

Andy

Love0

News

September 17, 2024

Virginia Governor Glenn Youngkin named BIO’s Governor of the Year

WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor…

Andy

Love0

News

September 17, 2024

Maryland Stem Cell Research Commission Announces $4.5 Million in Grants to Accelerate Stem Cell Innovations

COLUMBIA, Md., Sept. 17, 2024 /PRNewswire/ -- The Maryland Stem Cell Research Commission (MSCRC) announces the allocation of approximately $4.5…

Andy

Love0

News

AstraZeneca’s FluMist approved for self-administration in the US

USP Seeks Expert Volunteers for the 2025-2030 Cycle

MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases

Activation Capital Launches Start-the-Journey: Pre-Accelerator Program

ARPA-H Launches Initiative for Emerging Health Innovators

Astellas Announces FDA Listing of DIGITIVA™ for the Management of Heart Failure

BHI Partner Children’s National Innovation District: New federally supported hub to advance solutions for pediatric health emergencies

Fierce Biotech: NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines

Virginia Governor Glenn Youngkin named BIO’s Governor of the Year

Maryland Stem Cell Research Commission Announces $4.5 Million in Grants to Accelerate Stem Cell Innovations

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search